Compliance Rate

Compliance Rate 47.06%
Compliant submissions 8
Incompliant submissions 9
Total trials 17

My Organizations' Clinical Trials

Showing 700 of 867 entries
View as:

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT05264051 Org: User:
Start: 04/18/22 End: 03/01/27 Due: 03/01/28

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02122185 Org: User:
Start: 02/25/15 End: 02/25/27 Due: 02/25/28

Assessment of Paclitaxel-Induced Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT01953159 Org: User:
Start: 08/29/13 End: 12/31/27 Due: 12/31/28

Geriatric Assessment and Technology Evaluation in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06215508 Org: User:
Start: 04/30/26 End: 04/30/31 Due: 04/30/32

Intermuscular Coherence as a Biomarker for ALS

Phase: N/A Priority: Normal
NCT ID: NCT05104710 Org: User:
Start: 03/31/21 End: 12/31/25 Due: 12/31/26

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03571321 Org: User:
Start: 05/28/19 End: 09/05/27 Due: 09/05/28

Characterizing a 5P-Linked BHR Susceptibility Locus

Phase: N/A Priority: Normal
NCT ID: NCT00006512 Org: User:
Start: 09/30/00 End: 08/31/05 Due: 08/31/06

Brexpiprazole in Borderline Personality Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03418675 Org: User:
Start: 11/26/18 End: 04/14/21 Due: 04/14/22

Dexamethasone and Block Duration in Upper Extremity

Phase: N/A Priority: Normal
NCT ID: NCT01756573 Org: User:
Start: 01/31/13 End: 01/31/15 Due: 01/31/16

Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT03325465 Org: User:
Start: 01/22/18 End: 11/07/18 Due: 11/07/19

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT02213913 Org: User:
Start: 07/29/14 End: 07/29/23 Due: 07/29/24

A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00523432 Org: User:
Start: 08/31/07 End: 12/31/10 Due: 12/31/11

MRI Screening in Men at High Risk of Developing Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05608694 Org: User:
Start: 03/02/22 End: 03/01/39 Due: 03/01/40

Autologous Fat Grafting in Radiated Soft Tissue Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT05890196 Org: User:
Start: 03/01/23 End: 12/31/25 Due: 12/31/26

Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00583063 Org: User:
Start: 10/31/07 End: 04/30/08 Due: 04/30/09

Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT04954157 Org: User:
Start: 06/29/20 End: 04/21/22 Due: 04/21/23

Project ASPIRE Efficacy Pilot: Achieving Superior Parental Involvement for Rehabilitative Excellence

Phase: N/A Priority: Normal
NCT ID: NCT01753661 Org: User:
Start: 06/30/12 End: 02/28/15 Due: 02/28/16

Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00203931 Org: User:
Start: 03/31/05 End: 11/30/09 Due: 11/30/10

Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT05886764 Org: User:
Start: 10/23/23 End: 07/31/27 Due: 07/31/28

Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06291064 Org: User:
Start: 11/30/25 End: 06/30/32 Due: 06/30/33

Pain Assessment in the Intensive Care Unit

Phase: N/A Priority: Normal
NCT ID: NCT01628185 Org: User:
Start: 01/31/12 End: 07/31/14 Due: 07/31/15

To Determine if a Lower Extremity Strengthening Program Improve Quadriceps Muscle Strength

Phase: N/A Priority: Normal
NCT ID: NCT01080703 Org: User:
Start: 03/31/10 End: 01/31/14 Due: 01/31/15

Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT00452218 Org: User:
Start: 03/31/07 End: 05/31/12 Due: 05/31/13

Drugs Brain and Behavior (DDP)

Phase: N/A Priority: Normal
NCT ID: NCT04642820 Org: User:
Start: 11/01/20 End: 06/01/24 Due: 06/01/25

Effect of Omega-3 Supplementation During Pregnancy on Regulation of Stress

Phase: N/A Priority: Normal
NCT ID: NCT01158976 Org: User:
Start: 12/31/09 End: 06/30/13 Due: 06/30/14